Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Antares Pharma (NQ: ATRS )

4.590 USD +0.020 (+0.44%)
Streaming Delayed Price Updated: 12:19 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Antares Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million
Company updates full-year 2020 revenue guidance to $145-150 million 
From GlobeNewswire News Releases
Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
From GlobeNewswire News Releases
Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference
From GlobeNewswire News Releases
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
From GlobeNewswire News Releases
Antares Pharma to Report Third Quarter 2020 Financial and Operating Results
From GlobeNewswire News Releases
Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.
Antares Expands Urology Portfolio and Leverages Commercial Organization 
From GlobeNewswire News Releases
Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
From GlobeNewswire News Releases
Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations
Jack Howarth Retires as Vice President of Corporate Affairs 
From GlobeNewswire News Releases
Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance
From GlobeNewswire News Releases
Antares Pharma and Lunatus Enter Into an Exclusive Distribution Agreement for XYOSTED® in Saudi Arabia and the United Arab Emirates
From GlobeNewswire News Releases
Antares Pharma to Report Second Quarter 2020 Operating and Financial Results
From GlobeNewswire News Releases
First Commercial Product Using Antares Pharma’s Multi-Dose Pen Platform Launches in Europe
From GlobeNewswire News Releases
Antares Pharma Appoints Patrick Shea Senior Vice President of Commercial
From GlobeNewswire News Releases
Antares Pharma to Present at the Raymond James Human Health Innovation Conference
From GlobeNewswire News Releases
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
Antares Pharma Reports First Quarter 2020 Operating and Financial Results
From GlobeNewswire News Releases
Antares Pharma Reports Fourth Quarter and Full Year 2019 Operating and Financial Results
From GlobeNewswire News Releases
Antares Pharma to Present at the Cowen and Company 40th Annual Health Care Conference
From GlobeNewswire News Releases
Antares Pharma to Report Fourth Quarter and Full Year 2019 Financial and Operating Results
From GlobeNewswire News Releases
Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million
The Company Expects 2019 Net Revenue at Upper End or Exceed Range of $115 - $120 Million Guidance 
From GlobeNewswire News Releases
Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development
From GlobeNewswire News Releases
Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award
From GlobeNewswire News Releases
Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference
From GlobeNewswire News Releases
REMINDER: Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd.
Novel Drug Device Combination Product To Be Developed For The Treatment Of Suspected Acute Myocardial Infarction 
From GlobeNewswire News Releases
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd.
Novel Drug Device Combination Product To Be Developed For The Treatment Of Suspected Acute Myocardial Infarction 
From GlobeNewswire News Releases
Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference
From GlobeNewswire News Releases
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results
From GlobeNewswire News Releases
Antares Pharma Announces Receipt of Final Payment From Sale of Zomajet™ Needle-Free Delivery System
From GlobeNewswire News Releases
Antares Pharma to Report Third Quarter 2019 Financial and Operating Results
From GlobeNewswire News Releases
Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.